Concepedia
Statistics
Publications
15
Citations
250
H-Index
11
Active since
2009
Affiliations
University of Catania(Current)
Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele
Ospedale Garibaldi
University of Palermo
Azienda Usl 8 Arezzo
Maria Stella Pennisi is an author at University of Catania specializing in oncology, molecular oncology, and bcr-abl inhibitors.
Publications per year
2009–2021
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53
Elena Tirrò, Michele Massimino, Chiara Romano et al. · Frontiers in Oncology · 2019 · 32 citations · Full text
Medicine, Oncology, Pharmacology +17
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation
Michele Massimino, Maria Letizia Consoli, Maria Mesuraca et al. · Carcinogenesis · 2014 · 29 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells
Michele Massimino, Elena Tirrò, Stefania Stella et al. · Anticancer Research · 2018 · 24 citations · Full text
Medicine, Molecular Biology, Oncology +17
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib
Stefania Stella, Valentina Zammit, Silvia Rita Vitale et al. · International Journal of Molecular Sciences · 2019 · 22 citations · Full text
Medicine, Hematology, Pharmacology +10
BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors
Maria Stella Pennisi, Stefania Stella, Silvia Rita Vitale et al. · Frontiers in Oncology · 2019 · 18 citations · Full text
Medicine, Oncology, Pharmacology +12
1–5 of 15